OPUS 4 | Search

6 search hits

1 to 6

Sort by

Single versus double induction with "7+3" containing 60 versus 90 mg Daunorubicin for newly diagnosed AML: results from the randomized controlled SAL Dauno-double trial [Abstract] (2022)

Single or double induction with 7 + 3 containing standard or high-dose daunorubicin for newly diagnosed AML: the randomized DaunoDouble trial by the study alliance leukemia (2025)

Röllig, Christoph ; Steffen, Björn ; Schliemann, Christoph ; Mikesch, Jan-Henrik ; Alakel, Nael ; Herbst, Regina ; Hänel, Mathias ; Noppeney, Richard ; Hanoun, Maher ; Kaufmann, Martin ; Weinbergerova, Barbora ; Schäfer-Eckart, Kerstin ; Sauer, Tim ; Neubauer, Andreas ; Burchert, Andreas ; Baldus, Claudia D. ; Mertová, Jolana ; Jost, Edgar ; Niemann, Dirk ; Novák, Jan ; Krause, Stefan W. ; Scholl, Sebastian ; Hochhaus, Andreas ; Held, Gerhard ; Szotkowski, Tomas ; Rank, Andreas ; Schmid, Christoph ; Fransecky, Lars ; Kayser, Sabine ; Schaich, Markus ; Kramer, Michael ; Fiebig, Frank ; Haake, Annett ; Schetelig, Johannes ; Middeke, Jan Moritz ; Stölzel, Friedrich ; Platzbecker, Uwe ; Thiede, Christian ; Müller-Tidow, Carsten ; Berdel, Wolfgang E. ; Ehninger, Gerhard ; Mayer, Jiri ; Serve, Hubert ; Bornhäuser, Martin

Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B cell–type diffuse large B-cell lymphoma (2020)

Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML (2021)

Safety of front-line R-Mini-CHOP with or without Acalabrutinib in older adults with DLBCL - an interim analysis of serious adverse events in the Arched / GLA 2022-1 randomized, open-label, phase 3 trial [Abstract] (2024)

Christofyllakis, Konstantinos ; Age Kos, Igor ; Altmann, Bettina ; Poeschel, Viola ; Maurer, Stephanie ; Lesan, Vadim ; Bittenbring, Jörg-Thomas ; Kaddu-Mulindwa, Dominic ; Abdi, Zanir ; Ahlgrimm, Manfred ; Altmeyer, Sarah ; Fleser, Octavian ; Held, Gerhard ; Nickelsen, Maike ; Dreyling, Martin ; Zettl, Florian ; Buske, Christian ; Lenz, Georg ; Glass, Bertram ; Chapuy, Björn ; Schmitz, Norbert ; Ott, German ; Siebert, Reiner ; Viardot, Andreas ; Scherer, Florian ; Schmitz, Roland ; Rosenwald, Andreas ; Hellwig, Dirk ; Neuendorff, Nina ; Vassilakopoulos, Theodoros ; Doxani, Chrysoula ; Blatt, Pascal ; Nakisli, Oguzhan ; Schmidt, Susanne ; Gaska, Tobias ; Arndt, Börge ; Mueller, Matthias ; Witte, Hanno Maximilian ; Bentz, Martin ; Boehme, Volkmar ; Kirchen, Heinz ; Loeffler, Markus ; Kubuschock, Boris ; Gebauer, Niklas ; Mahlberg, Rolf ; Topaly, Julian ; Bott, Alexander ; Wille, Kai ; Trappe, Ralf Ulrich ; Rummel, Mathias J. ; Illerhaus, Gerald ; Brunner, Franziska ; Klump, Martin ; Kaiser, Ulrich ; Wessendorf, Swen ; Deligiannis, Iordanis ; Hildebrandt, Bert ; Kiani, Alexander ; Illmer, Thomas ; Prange-Krex, Gabriele ; Lerch, Kristina ; Sandmann, Matthias ; Broeckling, Sebastian ; Martens, Uwe ; von Tresckow, Bastian ; Heine, Annkristin ; Hebart, Holger F. ; Stilgenbauer, Stephan ; Thurner, Lorenz ; Bewarder, Moritz ; Ziepert, Marita

Fast-track schedule for vitamin D3 substitution in patients with newly diagnosed diffuse large B-cell lymphoma [Abstract] (2020)

Jabs, Jonas Matthias ; Poeschel, Viola ; Sökler, Martin ; Habersang, Kerstin ; Mahlberg, Rolf ; Keller, Ulrich ; Hoeffkes, Heinz-Gert ; Rank, Andreas ; Viardot, Andreas ; Neubauer, Andreas ; Ziepert, Marita ; Altmann, Bettina ; Stilgenbauer, Stephan ; Pfreundschuh, Michael ; Held, Gerhard ; Bittenbring, Joerg Thomas

1 to 6